FDA ACCEPTS ANTARES LICENSEE'S NDA FOR BIO-E-GEL.: An article from: Biotech Business Buy on Amazon
Facebook LinkedIn

FDA ACCEPTS ANTARES LICENSEE'S NDA FOR BIO-E-GEL.: An article from: Biotech Business

Publisher Worldwide Videotex
5.95 USD

Available for download now

Book Details
Publisher Worldwide Videotex
ISBN / ASIN B000FTBXG6
ISBN-13 978B000FTBXG2
Availability Available for download now
Sales Rank #99,999,999
Marketplace United States 🇺🇸
Ratings & Reviews No reviews yet — be the first!

No reviews yet.

Description
This digital document is an article from Biotech Business, published by Worldwide Videotex on June 1, 2006. The length of the article is 707 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA ACCEPTS ANTARES LICENSEE'S NDA FOR BIO-E-GEL.
Publication:Biotech Business (Newsletter)
Date: June 1, 2006
Publisher: Worldwide Videotex
Volume: 19 Issue: 6 Page: NA

Distributed by Thomson Gale
Donate to EbookNetworking
No Prev
No Next